Literature DB >> 29532909

The relationship between negative symptoms and depression in schizophrenia: a systematic review.

C R Krynicki1, R Upthegrove2, J F W Deakin3, T R E Barnes4.   

Abstract

OBJECTIVE: To provide an update on the evidence base for the nature of the relationship between negative symptoms and depressive features in people with schizophrenia, and propose new models that reflect their complex relationship.
METHOD: A systematic review following PRISMA guidelines. A total of 2210 articles were identified from EMBASE, PsychInfo and MEDLINE, and further two articles were hand-searched from references. Twenty-seven met inclusion criteria and were included in the review.
RESULTS: In schizophrenia, primary evidence suggests symptoms of low mood, suicidal ideation and pessimism have more specificity for depression whereas alogia and blunted affect may have more specificity as negative symptoms. Anhedonia, anergia and avolition may be common to both.
CONCLUSION: It may be possible to further distinguish depressive features from negative symptoms in schizophrenia when detailed phenomenology is considered. However, in a proposed dimensional model, these two domains continue to share certain phenomena, highlighting their close relationship.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  depression; schizophrenia

Mesh:

Year:  2018        PMID: 29532909     DOI: 10.1111/acps.12873

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  31 in total

1.  Progress in Schizophrenia Research and Treatment.

Authors: 
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

2.  The Psychopathology and Neuroanatomical Markers of Depression in Early Psychosis.

Authors:  Rachel Upthegrove; Paris Lalousis; Pavan Mallikarjun; Katharine Chisholm; Sian Lowri Griffiths; Mariam Iqbal; Mirabel Pelton; Renate Reniers; Alexandra Stainton; Marlene Rosen; Anne Ruef; Dominic B Dwyer; Marian Surman; Theresa Haidl; Nora Penzel; Lana Kambeitz-Llankovic; Alessandro Bertolino; Paolo Brambilla; Stefan Borgwardt; Joseph Kambeitz; Rebekka Lencer; Christos Pantelis; Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Eva Meisenzahl; Stephen J Wood; Nikolaos Koutsouleris
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

3.  Structural connectivity and risk for anhedonia after trauma: A prospective study and replication.

Authors:  Negar Fani; Vasiliki Michopoulos; Sanne J H van Rooij; Cherita Clendinen; Raven A Hardy; Tanja Jovanovic; Barbara O Rothbaum; Kerry J Ressler; Jennifer S Stevens
Journal:  J Psychiatr Res       Date:  2019-05-14       Impact factor: 4.791

4.  Comorbidity in Schizophrenia: Conceptual Issues and Clinical Management.

Authors:  Hussain Muhammad Abdullah; Hameed Azeb Shahul; Michael Y Hwang; Stephen Ferrando
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 5.  [Pharmacotherapy of schizophrenia].

Authors:  C U Correll
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

6.  Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.

Authors:  Wing Chung Chang; Ryan Wui Hang Ho; Jennifer Yee Man Tang; Corine Sau Man Wong; Christy Lai Ming Hui; Sherry K W Chan; Edwin M H Lee; Yi Nam Suen; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

7.  Factor Structure, Convergent, and Divergent Validity of the Prodromal Questionnaire-Negative Symptom Subscale.

Authors:  Katherine M Pierce; Seth D Maxwell; Thomas M Olino; Shanna Cooper; Lauren M Ellman
Journal:  Assessment       Date:  2020-01-19

8.  Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.

Authors:  Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith
Journal:  Schizophr Res       Date:  2021-01-23       Impact factor: 4.939

9.  Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.

Authors:  Daniel J Hauke; André Schmidt; Erich Studerus; Christina Andreou; Anita Riecher-Rössler; Joaquim Radua; Joseph Kambeitz; Anne Ruef; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Theresa Lichtenstein; Rachele Sanfelici; Nora Penzel; Shalaila S Haas; Linda A Antonucci; Paris Alexandros Lalousis; Katharine Chisholm; Frauke Schultze-Lutter; Stephan Ruhrmann; Jarmo Hietala; Paolo Brambilla; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Pantelis; Marlene Rosen; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Stefan Borgwardt
Journal:  Transl Psychiatry       Date:  2021-05-24       Impact factor: 6.222

Review 10.  Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients.

Authors:  Ali Mohammadkhanizadeh; Farnaz Nikbakht
Journal:  J Clin Neurosci       Date:  2021-07-20       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.